Sequential therapy with recombinant inte
β
H. H. Bartsch; K. Pfizenmaier; A. Hanusch; P. Scheurich; U. Γcer; G. A. Nagel
π
Article
π
1989
π
John Wiley and Sons
π
French
β 710 KB
Natural and recombinant interferons (IFNs) have already demonstrated therapeutic efficacy, including cytogenetic re- missions, in patients with chronic myelocytic leukemia (CML). We investigated at the level of ligand-receptor interaction the question whether heterogeneity of receptor number or affi